Saturday 17 October 2026
Export HSTM’s income statement to Excel — free account
HealthStream, Inc.
HSTM Healthcare Health Information Services
HealthStream, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $304.1 million, up 4.26% from fiscal 2024. In the quarter to June 2026, revenue grew 12.6%, EPS grew 27.8% and free cash flow grew 362.7%, each against the same quarter a year earlier. Dividend growth for three consecutive years, revenue growth for five.
33.13
0.62
−1.84%
Follow HSTM
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
37.85 | 30.91 | 37.82 | 41.53 |
+8 more quarters Free account |
P/S ratio |
2.48 | 1.95 | 2.28 | 2.81 | |
P/FCF ratio |
11.40 | 10.13 | 11.60 | 14.55 | |
P/Operating CF |
59.30 | 22.42 | 52.50 | 46.50 | |
P/B ratio |
2.23 | 1.73 | 1.96 | 2.40 | |
Price to Tangible BV |
9.49 | 8.04 | 9.68 | 7.47 | |
EV/Sales |
2.36 | 1.83 | 2.18 | 2.59 | |
EV/EBITDA |
9.04 | 7.10 | 8.69 | 9.92 | |
EV/Operating CF |
10.56 | 8.99 | 10.48 | 12.63 | |
EV/FCF |
10.85 | 9.49 | 11.12 | 13.43 | |
Quick Ratio |
0.84 | 0.81 | 0.77 | 1.12 | |
Current Ratio |
1.06 | 0.97 | 0.96 | 1.31 | |
Net Debt/EBITDA |
(2.88) | (3.00) | (3.38) | (4.29) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.63 | 0.59 | 0.59 | 0.60 | |
Operating CF/Net income |
2.01 | 4.59 | 5.20 | 2.96 | |
Capex/Depreciation |
(0.06) | (0.05) | (0.01) | (0.01) | |
Research and Development Expense of Revenue |
16.22% | 16.76% | 18.51% | 15.83% | |
Selling, General and Administrative Expense of Revenue |
25.72% | 25.81% | 28.43% | 25.46% | |
Intangible Assets out of Total Assets |
0.52 | 0.52 | 0.54 | 0.47 | |
Share Based Compensation of Revenue |
1.32% | 1.61% | 6.79% | 1.04% | |
Graham Net Nets |
(0.04) | (0.07) | (0.07) | 0.00 | |
Graham Number |
14.06 | 13.44 | 12.72 | 13.41 | |
Earnings Yield |
2.64% | 3.24% | 2.64% | 2.41% | |
Free Cash Flow Yield |
8.77% | 9.87% | 8.62% | 6.87% | |
Revenue per Share |
2.86 | 2.76 | 2.66 | 2.58 | |
Operating CF per Share |
0.46 | 0.92 | 0.44 | 0.61 | |
Capex per Share |
(0.03) | (0.03) | (0.01) | 0.00 | |
Free Cash Flow per Share |
0.43 | 0.90 | 0.43 | 0.60 | |
Cash per Share |
2.28 | 2.26 | 1.90 | 3.12 | |
Shareholders Equity per Share |
12.20 | 11.98 | 11.79 | 11.76 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
12.20 | 11.98 | 11.79 | 11.76 | |
Free Cash Flow |
12.52 | 26.40 | 13.03 | 17.92 | |
Working Capital |
7.59 | (3.49) | (4.49) | 35.08 | |
Capital Expenditures |
(0.91) | (0.74) | (0.16) | (0.11) | |
Net Current Asset Value |
(34.77) | (42.43) | (46.69) | (3.16) | |
EV/EBIT |
29.37 | 24.39 | 32.79 | 34.36 | |
Capex to Sales |
0.01 | 0.01 | 0.00 | 0.00 | |
Price to Operating Income |
30.87 | 26.03 | 34.22 | 37.23 | |
| Other line items | |||||
Average Receivables |
34.14 | 39.77 | 37.16 | 32.70 | |
Average Payables |
5.43 | 4.13 | 7.20 | 4.18 | |
Average Assets |
510.87 | 525.74 | 515.57 | 501.38 | |
Average Common Equity |
353.59 | 357.40 | 356.69 | 352.34 |
Columns are period end dates